• Health care innovation; Medicare coverage and reimbursement of telehealth and digital devices; Medicaid funding; Chronic disease management; Maternal health; Access to care; COVID-19 funding/waivers/flexibilities; Medicare Advantage; Funding for Providers; COVID Relief Provisions and Packages for Health Care Providers; Provider Relief Fund; FMAP; COVID Testing; Medicare coverage of tobacco cessation services; SDOH; Health equity; Health disparities; Medicare sequestration; Rural health and maternal health; Health care at home; Physician Fee Schedule reimbursement.
• 340B Drug Pricing Program; Chronic disease management; FCC Connected Care Initiative; Health Disparities/Health Inequities; Social Determinants of Health; Health Equity; COVID testing; PPE supply chain and funding.
• Funding for telehealth and digital health devices; Provider Relief Funding.
• US supply chain and Section 301 tariff exclusions for PPE.

Duration: October 18, 2018 to January 14, 2022

General Issues: Medicare/Medicaid, Health Issues, Budget/Appropriations, Trade (Domestic & Foreign)

Spending: about $760,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2018: Health Resources & Services Administration (HRSA), U.S. Senate, U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS), Agency for Healthcare Research & Quality (AHRQ), House of Representatives, Centers For Medicare and Medicaid Services (CMS)